GO
Loading...

Biotech could see more weakness: Pro

Monday, 24 Mar 2014 | 2:03 PM ET

Barbara Ryan, FTI Consulting, and Matt Maley, MillerTabek and Company, discuss what has propelled the massive sell-off in the biotech sector.